Navigation Links
Neurological Wellness Center Criticizes the U.S. Patent Office for Issuing a Patent for an Injection Site on the Human Body
Date:2/13/2013

(PRWEB) February 13, 2013

Unlike Dr. Burzenski’s antineoplastons, the drug used to effectively treat Alzheimer’s, Stroke and Traumatic Brain Injury is available at your local pharmacy. This drug, Enbrel, is used by over 400,000 Americans as a treatment for rheumatoid arthritis. However, for Enbrel to effectively treat Alzheimer’s, Stroke and TBI, it must be administered to the back of the neck precisely between cervical vertebrae C-5 and C-6. Only in the United States does a patent of an injection site on the human body have legal standing in a court of law.

Since 2010 Neurological Wellness Center has been providing hands-on individual instruction on the administration of this perispinal injection at their headquarters in Managua Nicaragua. Visit http://www.reversealzheimersnow.com.

For many, flying to Managua Nicaragua to receive this personalized training is an enormous expense and inconvenience. To overcome this problem, Neurological Wellness Center, under the direction of Augusto Ramirez, M.D., created Perispinal Enbrel Step-By-Step Instructional Video and accompanying e-book. This 24-minute video and 37-page e-book are now available online at http://www.neurological-recovery-guide.com.

Augusto Ramirez, M.D., Director of Neurological Wellness Center, a private medical group in Managua Nicaragua, authorized this press release.

Presently all FDA-approved drugs for the treatment of Alzheimer’s disease simply slow the rate of disease progression. Enbrel, when administered to the area between cervical vertebrae C-5 and C-6, enables the recovery of cognitive function, reversing impairments to memory, resulting in an improved sense of well-being and more engaging social interaction. A portion of those people treated with perispinal Enbrel injections will go on to live normal lives and eventually die of causes unrelated to Alzheimer’s disease.

Pharmaceutical companies generate billions of dollars annually selling drugs approved for the treatment of Alzheimer’s disease. The U.S. patent office, by granting patent 7214658, effectively makes it illegal for American physicians to treat Alzheimer’s disease by administering Enbrel perispinally. A physician who administers a subcutaneous injection of any drug to this area of the neck is in violation of patent 7214658. Administering such an injection exposes the physician to litigation and the prospect of being forced to pay a hefty fine for patent infringement.

The recent publication of an observational study involving 629 stroke and traumatic brain injury patients treated with perispinal Enbrel injections demonstrates the potential of perispinal Enbrel treatments to effectively address the unmet medical needs of millions of people living with impairments caused by stroke or TBI. Perispinal Enbrel’s efficacy extends to persons treated years after suffering a stroke or TBI.

"The U.S. Patent Office’s issuance of 7214658 not only serves to limit access to an alternative to the minimally effective Alzheimer’s treatment pharmaceuticals that are currently available, but importantly serves to limit access to a treatment for stroke and TBI, for which there is presently no other treatment available." Dr. Augusto Ramirez.

To enroll in a hands-on instructional course on perispinal injections visit http://www.reversealzheimersnow.com.

To purchase an instructional video and e-book on administering perispinal injections visit: http://www.neurological-recovery-guide.com.

To purchase Enbrel at the lowest prices in North America visit: http://www.genuine-enbrel-cheaper.com/.
To watch the movie Burzynski free visit: burzynskimovie.com/index.php?option=com_acajoom&act=mailing&task=view&listid=1&mailingid=62

Read the full story at http://www.prweb.com/releases/2013/2/prweb10375057.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Subcortical damage is primary cause of neurological deficits after awake craniotomy
2. New technology may help doctors monitor concussions, aging, and neurological function
3. NIH clinical trial begins for treatment of rare, fatal neurological disorder
4. Neurological Wellness Center Posts 700% Sales Increase in 2012; Enters Strategic Alliance with Enbrel Buyer's Club to Provide Low Cost Enbrel
5. Neurological Wellness Center Pays Tribute to Newly Released Study Announcing TBI Treatment Breakthrough
6. Neurological Wellness Center's Novel Neuro-Inflammation Inhibition Procedure that Induces Rapid Recovery from Alzheimer's, Stroke and Brain Injury is Now Being Taught in a Newly Released Video
7. University Hospitals Neurological Institute to present 6th International 2013 Epilepsy Colloquium
8. Cedars-Sinai physician-scientist awarded $3M to study most common inherited neurological disorder
9. The hidden disorder: Unique treatment proposed for childrens neurological disorder
10. New national clinical trials network for neurological disorders to foster cutting-edge treatments
11. Kids With Neurological Conditions at Higher Risk of Flu Death: CDC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... Conventional wisdom preaches ... success. In terms of the latter, setting the bar too high can result in ... than just slow progress toward their goal. , Research from PsychTests.com ...
(Date:6/24/2016)... ... ... was in a crisis. Her son James, eight, was out of control. Prone to extreme ... “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was ... other children and say he was going to kill them. If we were driving ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute ... Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s newest ... world, and the most handsome men, look naturally attractive. Plastic surgery should be ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group (VCG) ... held on June 20th at the Woodmont Country Club at 1201 Rockville Pike, Rockville, ... dedicated to helping service members that have been wounded in battle and their families. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: